mAbTree Biologics
Mabtree Biologics AG is a pioneering biopharmaceutical company based in Basel's Stucki Tech Park, focused on developing monoclonal antibody therapies to address critical healthcare gaps. Their mission is to innovate and develop proprietary human monoclonal antibodies for high unmet medical needs, transforming scientific breakthroughs into treatments for challenging diseases, and improving quality of life for patients with previously untreatable conditions. They aim to be a global leader in therapeutic antibodies, collaborating with partners to develop first-in-class or best-in-class therapies, especially in cancer and autoimmune diseases. The company has a strong research focus, building a rich pipeline of assets in immune diseases and oncology, and is committed to revolutionizing healthcare through groundbreaking antibody innovation.
Industries
Nr. of Employees
small (1-50)
mAbTree Biologics
Technologiepark Basel, Hochbergerstrasse 60c, 4057 Basel, Switzerland
Products
Pipeline of antibody therapeutics and antibody-drug conjugates
A pipeline of therapeutic assets comprising fully human affinity-matured antibodies and antibody-drug conjugates targeted at immuno-oncology and immune-mediated diseases.
Pipeline of antibody therapeutics and antibody-drug conjugates
A pipeline of therapeutic assets comprising fully human affinity-matured antibodies and antibody-drug conjugates targeted at immuno-oncology and immune-mediated diseases.
Services
Partnerships to enable access to third-party antibody technologies and co-development of antibody-based products across disease areas.
Discovery and early development services connecting antibody platform technologies with target and disease biology to generate differentiated therapeutic candidates.
Partnerships to enable access to third-party antibody technologies and co-development of antibody-based products across disease areas.
Discovery and early development services connecting antibody platform technologies with target and disease biology to generate differentiated therapeutic candidates.
Expertise Areas
- Therapeutic antibody discovery and engineering
- Antibody-drug conjugates (ADC) development
- Immuno-oncology
- Autoimmune disease therapeutics
Key Technologies
- Therapeutic antibody discovery platforms
- Affinity maturation techniques
- Antibody engineering
- Antibody-drug conjugate (ADC) platforms
News & Updates
Join the Evolution of Treatment
Partner with Mabtree Biologics to revolutionize healthcare through groundbreaking human antibody innovation.
Careers at Mabtree Biologics
Opportunities to join a global company with a life-changing mission, including roles for scientists and biotech professionals.
Development of Proprietary Monoclonal Antibodies
Focused on creating targeted antibodies to improve treatment options for cancer and autoimmune diseases.
Building a Rich Pipeline in Oncology and Immunology
Developing therapeutics designed to modulate the immune system and overcome cancer immune tolerance and escape.
Join the Evolution of Treatment
Partner with Mabtree Biologics to revolutionize healthcare through groundbreaking human antibody innovation.
Careers at Mabtree Biologics
Opportunities to join a global company with a life-changing mission, including roles for scientists and biotech professionals.
Development of Proprietary Monoclonal Antibodies
Focused on creating targeted antibodies to improve treatment options for cancer and autoimmune diseases.
Building a Rich Pipeline in Oncology and Immunology
Developing therapeutics designed to modulate the immune system and overcome cancer immune tolerance and escape.